Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M UNGER

Showing results (481-490 of 604) with videos related to

Pageof 61
Sort By:
Cancer|April 2, 2011
A phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430Jeffrey A Sosman, James Moon, Ralph J Tuthill, et al.
The Oncologist|September 22, 2020
Sex Representation in Clinical Trials Associated with FDA Cancer Drug Approvals Differs Between Solid and Hematologic MalignanciesShehara Mendis, Seerat Anand, Joanna M Karasinska, et al.
Investigational New Drugs|May 11, 2002
A phase II trial of pyrazine diazohydroxide in patients with disseminated malignant melanoma and no prior chemotherapy--Southwest Oncology Group studyRobert P Whitehead, Joseph M Unger, Lawrence E Flaherty, et al.
Journal of Neurology|December 25, 2010
Postprandial ghrelin response is reduced in patients with Parkinson's disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson's disease?Marcus M Unger, Jens C Möller, Katharina Mankel, et al.
Cancer|March 13, 2019
Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202N Lynn Henry, Joseph M Unger, Cathee Till, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2008
Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897Patricia A Ganz, Michael A Hussey, Carol M Moinpour, et al.
Journal of Acupuncture and Meridian Studies|June 24, 2015
Methods to Standardize a Multicenter Acupuncture Trial Protocol to Reduce Aromatase Inhibitor-related Joint Symptoms in Breast Cancer PatientsHeather Greenlee, Katherine D Crew, Jillian Capodice, et al.
Journal of the National Cancer Institute|August 28, 2016
Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention TrialJoseph M Unger, Cathee Till, Ian M Thompson, et al.
Transfusion|January 11, 2011
A randomized controlled trial comparing autologous radiolabeled in vivo platelet (PLT) recoveries and survivals of 7-day-stored PLT-rich plasma and buffy coat PLTs from the same subjectsLarry J Dumont, Deborah F Dumont, Zoe M Unger, et al.
JNCI Cancer Spectrum|August 10, 2023
Assessment of financial screening and navigation capabilities at National Cancer Institute community oncology clinicsAri Bell-Brown, Kate Watabayashi, Debbie Delaney, et al.
Pageof 61

Showing results (481-490 of 604) with videos related to

Sort By:
Pageof 61
Cancer|April 2, 2011
A phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430Jeffrey A Sosman, James Moon, Ralph J Tuthill, et al.
The Oncologist|September 22, 2020
Sex Representation in Clinical Trials Associated with FDA Cancer Drug Approvals Differs Between Solid and Hematologic MalignanciesShehara Mendis, Seerat Anand, Joanna M Karasinska, et al.
Investigational New Drugs|May 11, 2002
A phase II trial of pyrazine diazohydroxide in patients with disseminated malignant melanoma and no prior chemotherapy--Southwest Oncology Group studyRobert P Whitehead, Joseph M Unger, Lawrence E Flaherty, et al.
Journal of Neurology|December 25, 2010
Postprandial ghrelin response is reduced in patients with Parkinson's disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson's disease?Marcus M Unger, Jens C Möller, Katharina Mankel, et al.
Cancer|March 13, 2019
Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202N Lynn Henry, Joseph M Unger, Cathee Till, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2008
Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897Patricia A Ganz, Michael A Hussey, Carol M Moinpour, et al.
Journal of Acupuncture and Meridian Studies|June 24, 2015
Methods to Standardize a Multicenter Acupuncture Trial Protocol to Reduce Aromatase Inhibitor-related Joint Symptoms in Breast Cancer PatientsHeather Greenlee, Katherine D Crew, Jillian Capodice, et al.
Journal of the National Cancer Institute|August 28, 2016
Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention TrialJoseph M Unger, Cathee Till, Ian M Thompson, et al.
Transfusion|January 11, 2011
A randomized controlled trial comparing autologous radiolabeled in vivo platelet (PLT) recoveries and survivals of 7-day-stored PLT-rich plasma and buffy coat PLTs from the same subjectsLarry J Dumont, Deborah F Dumont, Zoe M Unger, et al.
JNCI Cancer Spectrum|August 10, 2023
Assessment of financial screening and navigation capabilities at National Cancer Institute community oncology clinicsAri Bell-Brown, Kate Watabayashi, Debbie Delaney, et al.
Pageof 61